G-Protein Coupled Receptors (GPCRs) Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />
to Exceed US$3.53 bn by 2022, Boosted by<br />
Focus on Drug Discovery<br />
As ADME toxicity studies and drug discovery projects worldwide call<br />
for the use of more advanced GPCR assays, platforms, and systems, the<br />
demand for G-protein coupled receptors (<strong>GPCRs</strong>) is expected to be on<br />
the growth path.<br />
A latest report by Transparency <strong>Market</strong> Research states that the global<br />
<strong>GPCRs</strong> market will rise in value to reach US$3.53 bn by 2022, up from<br />
its 2013 valuation of US$1.63 bn. This translates to an 8.8% CAGR<br />
between 2014 and 2022.The report is titled, “G-<strong>Protein</strong> <strong>Coupled</strong><br />
<strong>Receptors</strong> (<strong>GPCRs</strong>) <strong>Market</strong> Global Industry Analysis, Size, Share,<br />
Growth, Trends and Forecast 2014 – 2022.<br />
The <strong>GPCRs</strong> market is composed of various types of kits and assays that<br />
aid the process of drug discovery and development. G-protein coupled<br />
receptors refer to a group of surface receptors that respond to different<br />
kinds of external stimuli. This cell-communication ability makes them<br />
useful in a variety of pharmacology processes. A significant factor to<br />
consider when understanding what drives the global <strong>GPCRs</strong> market is<br />
that over 30% of the drugs available on the market today target <strong>GPCRs</strong>.<br />
Besides this, a vast number of drugs currently at the clinical or<br />
preclinical stage target <strong>GPCRs</strong>.<br />
The report segments the global <strong>GPCRs</strong> market on the basis of assay<br />
type, therapeutic areas, and by geography. By assay type, the market has<br />
been segmented into: calcium level detection assays, cGMP assays,<br />
GTPγS binding assays, receptor internalization assays, reporter gene
assays, and cAMP Assays. The largest segment among these is the<br />
cAMP assays segment, which accounted for 32.5% of the market in<br />
2013. The segment, however, will not be the fastest growing segment<br />
through the report’s forecast period but will exhibit the second-fastest<br />
rate of growth.<br />
Considerable promise will also be shown by the reporter gene assays<br />
segment, which is predicted to log a considerably high CAGR through<br />
the report’s forecast period. An upswing in the demand for<br />
technologically advanced and accurate assays and systems will be<br />
responsible for the robust growth of the gene assays segment.<br />
Browse Full Research Report on G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong><br />
(<strong>GPCRs</strong>) <strong>Market</strong>:<br />
http://www.transparencymarketresearch.com/g-protein-coupledreceptors-market.html<br />
Basis therapeutic areas, the report segments the market into: Central<br />
nervous system (CNS), cardiovascular system, immune system,<br />
oncology, respiratory system, reproductive system, and others. Among<br />
these segments, oncology represented the largest segment by revenue<br />
and will remain the dominant segment over the report’s forecast period.<br />
The attractiveness of oncology therapies for companies in the <strong>GPCRs</strong><br />
market can be credited to the high prevalence of cancer globally. In<br />
2013, the central nervous system (CNS) segment followed oncology in<br />
terms of revenue. The cardiovascular segment stood third globally. Other<br />
GPCR therapeutic segments such as immune system, respiratory, and<br />
reproductive are projected to exhibit strong growth through the report’s<br />
forecast period.<br />
The report also studies the global <strong>GPCRs</strong> market On the basis of<br />
geography, the market is segmented into North America, Europe, Asia
Pacific, and Rest of the World. According to the TMR report, the global<br />
G-protein coupled receptors market was led by North America in 2013<br />
because of the heightened awareness that prevails about the use of<br />
advanced assays and the relative affluence of consumers, which enables<br />
them to afford high-end treatments. This regional market will report high<br />
growth till 2022 owing chiefly to the rise in geriatric patients and people<br />
suffering from obesity.<br />
Browse Full Press Release on G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong><br />
(<strong>GPCRs</strong>) <strong>Market</strong>:<br />
Press Release<br />
About Us<br />
Transparency <strong>Market</strong> Research (TMR) is a global market intelligence<br />
company providing business information reports and services. The<br />
company’s exclusive blend of quantitative forecasting and trend analysis<br />
provides forward-looking insight for thousands of decision makers.<br />
TMR’s experienced team of analysts, researchers, and consultants use<br />
proprietary data sources and various tools and techniques to gather and<br />
analyze information.<br />
TMR’s data repository is continuously updated and revised by a team of<br />
research experts so that it always reflects the latest trends and<br />
information. With extensive research and analysis capabilities,<br />
Transparency <strong>Market</strong> Research employs rigorous primary and secondary<br />
research techniques to develop distinctive data sets and research material<br />
for business reports.
Contact Us<br />
Transparency <strong>Market</strong> Research<br />
State Tower,<br />
90 State Street, Suite 700,<br />
Albany NY - 12207<br />
United States<br />
USA - Canada Toll Free: 866-552-3453<br />
Email: sales@transparencymarketresearch.com<br />
Website: http://www.transparencymarketresearch.com